Indoleamine 2,3-dioxygenase: Distribution and function in the developing human placenta

Journal of Reproductive Immunology

Volumn 61, Issue 2, 2004, Pages 87-98

  Kudo, Yoshiki ^a,d   Boyd, C A R ^a   Spyropoulou, Isabella ^b   Redman, C W G ^b   Takikawa, Osamu ^c   Katsuki, Takafumi ^d   Hara, Tetsuaki ^d   Ohama, Koso ^d   Sargent, I L ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HOKKAIDO UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Human blastocysts; Human placenta; Indoleamine 2,3 dioxygenase; Pregnancy; Tryptophan

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN;

ARTICLE; BLASTOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; EMBRYO; ENZYME ACTIVATION; ENZYME LOCALIZATION; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONONUCLEAR CELL; MOTHER FETUS RELATIONSHIP; PHYSIOLOGY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STROMA; SYNCYTIOTROPHOBLAST; TISSUE GROWTH;

ANTIVIRAL AGENTS; BLASTOCYST; CELL DIVISION; CULTURE TECHNIQUES; EXTRAEMBRYONIC MEMBRANES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; T-LYMPHOCYTES; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

EID: 1842507880     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2003.11.004     Document Type: Article

References (20)

1. Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., MacDonald S., Pulford K.A., Stein H., Mason D.Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32:1984;219-229.
2. Hwu P., Du M.X., Lapointe R., Do M., Taylor M.W., Young H.A. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164:2000;3596-3599.
3. Kamimura S., Eguchi K., Yonezawa M., Sekiba K. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med. Okayama. 45:1991;135-139.
4. King A., Burrows T., Verma S., Hiby S., Loke Y.W. Human uterine lymphocytes. Hum. Reprod. Update. 4:1998;480-485.
5. Kudo Y., Boyd C.A.R. Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim. Biophys. Acta. 1500:2000;119-124.
6. Kudo Y., Boyd C.A.R. The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants. J. Physiol. 531:2001;417-423.
7. Kudo Y., Boyd C.A.R., Sargent I.L., Redman C.W.G. Modulation of indoleamine 2,3-dioxygenase by interferon-γ in human placental chorionic villi. Mol. Hum. Reprod. 6:2000;369-374.
8. Kudo Y., Boyd C.A.R., Sargent I.L., Redman C.W.G. Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J. Physiol. 535:2001;207-215.
9. Martin K.L., Barlow D.H., Sargent I.L. Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium. Hum. Reprod. 13:1998;1645-1652.
10. Medawar P.B. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 7:1953;320-328.
11. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., Munn D.H. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2:2001;64-68.
12. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1999;1363-1372.
13. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 281:1998;1191-1193.
14. Santoso D.I.S., Rogers P., Wallace E.M., Manuelpillai U., Walker D., Subakir S.B. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta. 23:2002;373-379.
15. Sedlmayr P., Blaschitz A., Wintersteiger R., Semlitsch M., Hammer A., MacKenzie C.R., Walcher W., Reich O., Takikawa O., Dohr G. Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol. Hum. Reprod. 8:2002;385-391.
16. Siman C.M., Sibley C.P., Jones C.J., Turner M.A., Greenwood S.L. The functional regeneration of syncytiotrophoblast in cultured explants of term placenta. Am. J. Physiol. 280:2001;R1116-R1122.
17. Suzuki S., Tone S., Takikawa O., Kubo T., Kohno I., Minatogawa Y. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem. J. 355:2001;425-429.
18. Takikawa O., Kuroiwa T., Yamazaki F., Kido R. Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263:1988;2041-2048.
19. Watson A.L., Palmer M.E., Burton G. Human chorionic gonadotrophin release and tissue viability in placental organ culture. Hum. Reprod. 10:1995;2159-2164.
20. Yamazaki F., Kuroiwa T., Takikawa O., Kido R. Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem. J. 230:1985;635-638.